Source:http://linkedlifedata.com/resource/pubmed/id/15297801
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2004-9-8
|
pubmed:abstractText |
To evaluate the influence of the incidence and unawareness of hypoglycemia on lymphocyte beta2-adrenoceptor densities, we measured beta2-adrenoceptor density using [125I]-iodocyanopindolol and CGP 12177 before and after 1 week of treatment optimization in 33 adults with type-1 diabetes mellitus. Diabetes treatment of all patients was modified to improve their glycemic control. During this week, all patients had to complete a protocol with 7 daily glucose measurements, one of which was at night. The subjective symptoms were evaluated in case of hypoglycemia. A significant correlation between a hypoglycemia incidence below (but not above) the threshold of 2.75 mmol/l (50 mg/dl) and beta2-adrenoceptor densities on lymphocytes was found after the study week (r = -0.72, p < 0.00001). Nine patients suffering from hypoglycemia unawareness had a significantly higher incidence of hypoglycemia (p < 0.002) and lower beta2-adrenoceptor densities on lymphocytes compared to 24 patients who recognized all of their hypoglycemic episodes (p < 0.004). We conclude that downregulation of beta2-adrenoceptor densities on lymphocytes occurs as a result of recurrent hypoglycemia defined as glucose levels of < 2.75 mmol/l. Beta2-adrenoceptor densities are decreased in patients with subjective hypoglycemia unawareness and might contribute to the reduced beta-adrenergic sensitivity in this subgroup of patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-0163
|
pubmed:author | |
pubmed:copyrightInfo |
2004 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-41
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15297801-Adolescent,
pubmed-meshheading:15297801-Adult,
pubmed-meshheading:15297801-Awareness,
pubmed-meshheading:15297801-Diabetes Mellitus, Type 1,
pubmed-meshheading:15297801-Down-Regulation,
pubmed-meshheading:15297801-Female,
pubmed-meshheading:15297801-Humans,
pubmed-meshheading:15297801-Hypoglycemia,
pubmed-meshheading:15297801-Male,
pubmed-meshheading:15297801-Middle Aged,
pubmed-meshheading:15297801-Receptors, Adrenergic, beta-2,
pubmed-meshheading:15297801-Signal Transduction,
pubmed-meshheading:15297801-Sympathetic Nervous System
|
pubmed:year |
2004
|
pubmed:articleTitle |
Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with Type-1 diabetes?
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, University of Würzburg, Germany. schwab@kikli.ukl.uni-freiburg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|